Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 4:10 pm Purchase | 2026-05-11 | 13G | STAAR SURGICAL CO STAA | Point72 Asset Management, L.P. | 2,591,498 5.200% | 2,591,498 (New Position) | Filing History |
| 2026-05-08 4:10 pm Purchase | 2026-05-07 | 13G | ATARA BIOTHERAPEUTICS INC ATRA | Point72 Asset Management, L.P. | 526,682 6.200% | 518,035 (+5990.92%) | Filing History |
| 2026-05-01 4:10 pm Purchase | 2026-04-24 | 13G | SUTRO BIOPHARMA INC STRO | Point72 Asset Management, L.P. | 946,829 5.700% | 647,084 (+215.88%) | Filing History |
| 2026-04-29 5:31 pm Unchanged | 2026-04-28 | 13G | JANUX THERAPEUTICS INC JANX | Point72 Asset Management, L.P. | 3,069,759 5.000% | 0 (Unchanged) | Filing History |
| 2026-04-29 5:30 pm Purchase | 2026-04-28 | 13G | JANUX THERAPEUTICS INC JANX | Point72 Asset Management, L.P. | 3,069,759 5.000% | 3,069,759 (New Position) | Filing History |
| 2026-04-23 4:59 pm Purchase | 2026-04-22 | 13G | SURROZEN INC SRZN | Point72 Asset Management, L.P. | 615,957 5.400% | 615,957 (New Position) | Filing History |
| 2026-04-16 4:10 pm Purchase | 2026-04-15 | 13G | CYTOMX THERAPEUTICS INC CTMX | Point72 Asset Management, L.P. | 10,864,581 5.000% | 6,796,006 (+167.04%) | Filing History |
| 2026-04-06 4:26 pm Purchase | 2026-04-02 | 13G | HMH HLDG INC HMH | Point72 Asset Management, L.P. | 575,000 5.500% | 575,000 (New Position) | Filing History |
| 2026-04-02 4:10 pm Sale | 2026-03-26 | 13G | KODIAK SCIENCES INC KOD | Point72 Asset Management, L.P. | 609,806 1.000% | -1,557,123 (-71.86%) | Filing History |
| 2026-04-01 5:32 pm Purchase | 2026-03-25 | 13G | VERA THERAPEUTICS INC VERA | Point72 Asset Management, L.P. | 1,229,525 1.700% | 1,229,525 (New Position) | Filing History |
| 2026-03-11 5:24 pm Purchase | 2026-03-10 | 13G | KORRO BIO INC KRRO | Point72 Asset Management, L.P. | 816,885 5.700% | 540,054 (+195.08%) | Filing History |
| 2026-03-10 6:41 pm Sale | 2025-12-31 | 13G | CELLDEX THERAPEUTICS INC C CLDX | Point72 Asset Management, L.P. | 1,758,357 2.600% | -2,706,043 (-60.61%) | Filing History |
| 2026-03-03 4:25 pm Purchase | 2026-02-24 | 13G | EDESA BIOTECH INC EDSA | Point72 Asset Management, L.P. | 600,000 7.200% | 600,000 (New Position) | Filing History |
| 2026-02-23 6:09 pm Purchase | 2026-02-18 | 13G | BETA BIONICS INC BBNX | Point72 Asset Management, L.P. | 2,290,023 5.200% | 2,290,023 (New Position) | Filing History |
| 2026-02-19 4:59 pm Purchase | 2026-02-17 | 13G | Q32 BIO INC QTTB | Point72 Asset Management, L.P. | 2,057,308 9.900% | 2,057,308 (New Position) | Filing History |
| 2026-02-18 5:42 pm Purchase | 2026-02-17 | 13G | OKYO PHARMA LTD SHS USD OKYO | Point72 Asset Management, L.P. | 4,058,445 7.900% | 4,058,445 (New Position) | Filing History |
| 2026-02-17 4:36 pm Purchase | 2025-12-23 | 13G | CENTURY THERAPEUTICS INC IPSC | Point72 Asset Management, L.P. | 5,961,563 6.800% | 1,235,924 (+26.15%) | Filing History |
| 2026-02-17 4:35 pm Purchase | 2025-12-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | Point72 Asset Management, L.P. | 2,981,674 6.900% | 860,534 (+40.57%) | Filing History |
| 2026-02-17 4:35 pm Sale | 2025-12-31 | 13G | KODIAK SCIENCES INC KOD | Point72 Asset Management, L.P. | 2,166,929 3.500% | -741,907 (-25.51%) | Filing History |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | WOLFSPEED INC DEL COM WOLF | Point72 Asset Management, L.P. | 990,150 3.800% | -555,837 (-35.95%) | Filing History |